s6y

Accustem Sciences Inc.

Ticker
ACUT
CIK
1850767
Industry
Pharmaceutical Preparations
Formerly
AccuStem Sciences Ltd

Financials 30

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  3. 10-Q Quarterly Report for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  7. 10-Q Quarterly Report for period ending Sep 30, 2025
  8. 10-Q Quarterly Report for period ending Jun 30, 2025
  9. 10-Q Quarterly Report for period ending Mar 31, 2025
  10. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2025

All 30 financials filings

News 12

  1. 8-K Current report filing
  2. 8-K/A Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 12 news filings

Ownership 17

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 17 ownership filings

Prospectus 3

  1. S-1/A General form of registration statement for all companies including face-amount certificate companies
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Proxies 3

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

Other 13

  1. SEC STAFF ACTION
  2. SEC STAFF ACTION
  3. EFFECT Notice of Effectiveness
  4. F-6 Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
  5. UPLOAD Letter (PDF)
  6. 20FR12G/A Form for initial registration of a class of securities of foreign private issuers pursuant to Section 12(g)
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. 20FR12G/A Form for initial registration of a class of securities of foreign private issuers pursuant to Section 12(g)
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 13 other filings